MOH — authorised 14 June 1965
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
MOH authorised Maolate on 14 June 1965
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 14 June 1965.
PHARMACIA AND UPJOHN holds the Israeli marketing authorisation.